EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT

K Gadsbøll iD, I Vogel iD, S E Kristensen iD, L H Pedersen iD, J Hyett iD, O B Petersen iD, Danish Cytogenetic Central Register study group

Ultrasound in Obstetrics & Gynecology · 2024-10 · 64 (4) · 470-479

DOI: 10.1002/uog.27667 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 04.09.2024. Verfasst von K Gadsbøll und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal Medicine, Pregnancy and Ultrasound, Department of Gynecology, Fertility, and Obstetrics, Copenhagen University Hospital, Rigshospita…. Hauptthemen laut MEDLINE: Pregnancy Trimester, First, Down Syndrome, Chromosome Aberrations. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Our aim was to examine the prenatal profiles of pregnancies affected by an atypical chromosomal aberration, focusing on pathogenic copy‐number variants (pCNVs). We also wanted to quantify the performance of combined first‐trimester screening (cFTS) and a second‐trimester anomaly scan in detecting these aberrations. Finally, we aimed to estimate the consequences of a policy of using non‐invasive prenatal testing (NIPT) rather than invasive testing with chromosomal microarray analysis (CMA) to manage pregnancies identified as high risk by cFTS.

Methods

This was a retrospective review of the Danish Fetal Medicine Database of all pregnant women who underwent cFTS and a risk assessment for trisomy 21 between 1 January 2008 and 31 December 2018. Chromosomal aberrations diagnosed prenatally, postnatally or from fetal tissue following pregnancy loss or termination of pregnancy were identified. Chromosomal aberrations were grouped into one of six categories: triploidy; common trisomy (13, 18 or 21); monosomy X; other sex‐chromosome aberration (SCA); pCNV; and rare autosomal trisomy (RAT) or mosaicism. The prevalence of each aberration category was stratified by the individual cFTS markers and trisomy 21 risk estimate, and the size of each pCNV diagnosed by CMA was calculated.

Results

We retrieved data on 565 708 pregnancies, of which 3982 (0.70%) were diagnosed with a fetal chromosomal aberration. cFTS identified 87% of the common trisomies, but it also performed well in identifying triploidies (86%), monosomy X (92%), atypical SCAs (58%) and RATs or mosaicisms (70%). pCNVs comprised 27% ( n = 1091) of the chromosomal aberrations diagnosed overall, and the prevalence increased during the study period, as prenatal CMA was increasingly being performed. In pregnancies with a maternal age < 30 years, nuchal translucency (NT) thickness ≤ 95 th centile, pregnancy‐associated plasma protein‐A (PAPP‐A) ≥ 1 multiple of the median, or trisomy 21 risk of ≤ 1 in 1000, the prevalence of pCNVs exceeded significantly the prevalence of trisomies 21, 18 and 13. Pregnancies affected by a pCNV had significantly increased NT and decreased levels of the maternal biomarkers PAPP‐A and β‐human chorionic gonadotropin compared with unaffected pregnancies. However, only 23% of these pregnancies screened positive on cFTS and 51% of pCNVs were not detected until after birth. Among high‐risk pregnancies, pCNVs comprised 14% of diagnosed aberrations, and when other atypical aberrations were considered, conventional NIPT (screening for trisomies 21, 18 and 13 and monosomy X) would miss 27% of all pathogenic aberrations diagnosed from invasive testing following a high‐risk cFTS result. Thus, 1 in 26 pregnancies at high risk following cFTS would be affected by a chromosomal aberration despite a normal result from conventional NIPT. In a contingent screening model using NIPT for the ‘intermediate’‐risk group (trisomy 21 risk of 1 in 100–299), 50% of the aberrations would be missed. In our cohort, 79% of the pCNVs diagnosed were < 5Mb and therefore not detectable using current forms of ‘genome‐wide’ NIPT.

Conclusions

As a by‐product of screening for trisomies 21, 18 and 13, most triploidies and the majority of atypical SCAs, RATs and mosaicisms are detected before birth. However, only 23% of pCNVs are associated with a high‐risk result according to cFTS and only half are diagnosed before birth. Replacing invasive testing with NIPT for high‐risk pregnancies would substantially decrease the first‐trimester detection of pathogenic chromosomal anomalies. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Trimester, FirstDown SyndromeChromosome AberrationsHumansFemalePregnancyDenmarkRetrospective StudiesAdultNoninvasive Prenatal TestingChromosome DisordersRisk AssessmentPregnancy Trimester, SecondDNA Copy Number VariationsTrisomyPrenatal DiagnosisNuchal Translucency Measurement

Stichwörter der Autor:innen

CNVNIPTatypical chromosomal aberrationcFTScombined first‐trimester screeningcombined testingcopy‐number variantnon‐invasive prenatal testingrisk assessment

Autor:innen und Institutionen

  • Center for Fetal Medicine, Pregnancy and Ultrasound, Department of Gynecology, Fertility, and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Center for Fetal Diagnostics, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.

ORCID-Profile: K Gadsbøll, I Vogel, S E Kristensen, L H Pedersen, J Hyett, O B Petersen

Förderung

  • Novo Nordisk Fonden

Zitieren

APA

Gadsbøll, K., Vogel, I., Kristensen, S. E., Pedersen, L. H., Hyett, J., Petersen, O. B., & Danish Cytogenetic Central Register study group (2024). Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT. Ultrasound in Obstetrics & Gynecology, 64(4), 470-479. https://doi.org/10.1002/uog.27667

Vancouver

Gadsbøll K, Vogel I, Kristensen SE, Pedersen LH, Hyett J, Petersen OB, et al. Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT. Ultrasound in Obstetrics & Gynecology. 2024;64(4):470-479. doi:10.1002/uog.27667

BibTeX
@article{Gadsbll2024,
  author = {Gadsbøll, K and Vogel, I and Kristensen, S E and Pedersen, L H and Hyett, J and Petersen, O B and Danish Cytogenetic Central Register study group, Danish Cytogenetic Central Register study group},
  title = {Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2024},
  volume = {64},
  number = {4},
  pages = {470--479},
  doi = {10.1002/uog.27667}
}
Kostenlos starten →